Telavancin Hydrochloride

• Status: Validated • Patent Expiration: US：2023.07.20 ；CN：off-patent • Usage: Oncology

• Status: DMF No.:032020 • Patent Expiration: Off-patent • Usage: Oncology

• Status: DMF No.: 028803 • Patent Expiration: US：2027.03.04; • Usage: Anti-infection

Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes fondaparinux sodium. It belongs to cardiovascular category. Contact us for more information.

• Status:  • DMF No.:031449 • ASMF Approved • MF No.: 230MF10169 • Patent Expiration: Off-patent • Usage:Antifungal

• Status: DMF No.: 028314 • Patent Expiration: Off-patent • Usage: Antifungal

• Status: Validated • Patent Expiration: ODE：2022.10.23；NCE：2020.10.23 • Usage: Oncology

• Status: Pre-validation • Patent Expiration: US：2022.11 • Usage: Intestinal Ostruction

• Status: DMF No.:032346 • Patent Expiration: Off-patent • Usage: Antifungal

• Status: DMF No.:030886 • Patent Expiration: Off-patent • Usage: Antifungal

• Status: DMF No. :033904 • Patent Expiration: US：2021.01.27； CN：2020.11.23 • Usage:Selective relaxant binding agent 

• Status: Validated • Patent Expiration: CN：2021.7；US：2032.8 • Usage: AntiHBV